期刊文献+

腹泻对肾移植受者他可莫司血药浓度的影响 被引量:13

Effect of diarrhea on tacrolimus blood trough levels in kidney transplantation recipients
下载PDF
导出
摘要 目的:观察腹泻对肾移植受者他克莫司谷浓度的影响,并探讨其发生的可能原因和机制。方法:观察了肾移植术后出现腹泻的患者27例,在他克莫司和环孢素治疗组中分别有20例和7例。观察了围腹泻期药物剂量及谷浓度变化,并进行了与腹泻相关病原学检查。结果:在腹泻期间分别有15例(75%)和2例(28.6%)患者他克莫司和环孢素谷浓度明显升高。通过抗感染、减低霉酚酸酯剂量及止泻等综合治疗,腹泻治愈,他克莫司谷浓度在腹泻愈后3~17 d内下降至治疗范围。结论:腹泻是引起他克莫司谷浓度升高的重要因素。腹泻期间应适当减低他克莫司剂量和密切监测他克莫司谷浓度变化。 Objective:To observe the effect of diarrhea on tacrolimus (Tac) trough levels in renal transplant reciepients, and to analyze possible factors and mechanisms contributed to the episode. Methodology:Twenty-seven cases with diarrhea were observed after renal transplantation. 20 cases were received triple immunosuppressive protocols in Tac incombination with myeophenolate mofetil (MMF) and prednisone, and 7 cases were in cyclosporine ineombination with MMF and prednisone, respectively. We retrospectively reviewed changes of Tac and eyelosporine trough levels before, during and after diarrhea, respectively. Moreover, some etiological laboratory tests related to diarrhea, such as feces routine test, feces smear and rotavirus immunodetection in feces specimen, were performed. Results:Diarrhea mainly resulted from MMF-induced and gastroenteritis after transplantation. The Tac trough levels were significantly elevated during diarrhea in 15 ( 75% ) recipients, whereas there were only 2 ( 28. 6% ) with elevated cyclosporine trough levels in the observed patients, compared with therapeutical ranges before diarrhea episode. The combined therapy, including treatment of antidiarrhoeal drug, reducing MMF doses and administration of antibiotics, had a good efficacy on diarrhea. The Tae trough levels were returned to target range between 3 - 17 days since the patients stopping diarrhea. The cyclosporine trough levels decreased below therapeutical ranges on day 2 after reducing dose. All of the patients have not any a episode of acute rejection during observation. Effect of diarrhea on levels of serum creatinine was not found in this study. Conclusion: Diarrhea following kidney transplantation could significantly result in elevated Tac but not cyclosporine trough levels. Until fully recovery from diarrhea, Tac trough levels were gradually returned to therapeutical range. Disruption of the intestinal epithelial barrier cells and non-specific colonic absorption of Tac may lead to extreme elevations in blood Tac levels. In order to prevent any a possible toxical effect of high blood Tac concentration during diahhea, antibiotic therapy to diarrhea, reduction of MMF dose, and modulation of Tac dosage are necessary.
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 北大核心 2009年第5期406-409,437,共5页 Chinese Journal of Nephrology,Dialysis & Transplantation
关键词 肾移植 他克莫司 腹泻 血药谷浓度 kidney transplantation tacrolimus diarrhea trough levels
  • 相关文献

参考文献18

  • 1Van Mourik ID, Kelly DA. Immunosuppressive drugs in paediatric liver transplantation. Paediatr Drugs, 2001,3 (1) : 43 -60.
  • 2Van Gelder T. Drug interactions with tacrolimus. Drug Saf, 2002, 25(10) : 707 -712.
  • 3贾晋生,武丽娟,李雪琴.抗菌药物相关性腹泻的诊断[J].中华医院感染学杂志,2005,15(8):872-872. 被引量:6
  • 4Maes B, Hadaya K, de Moor B, et al. Severe diarrhea in renal transplant patients : results of the DIDACT study. Am J Transplant, 2006, 6(6) :1466 - 1472.
  • 5Givon-Lavi N, Greenberg D, Dagan R. Comparison between two severity scoring scales commonly used in the evaluation of rotavirus gastroenteritis in children. Vaccine, 2008, 26(46) : 5798 -5801.
  • 6唐科仕,卢一平,王莉,杨宇如.霉酚酸酯治疗慢性移植肾肾病的探讨(附9例报告)[J].肾脏病与透析肾移植杂志,2001,10(4):335-337. 被引量:7
  • 7Heller T, van Gelder T, Budde K, et al. Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients. Am J Transplant, 2007, 7 (7) : 1822 - 1831.
  • 8Lemahieu W, Maes B, Verheke K, et al. Cytochrome P450 3A4 and P-glyeoprotein Activity and Assimilation of Taerolimus in Transplant Patients with Persistent Diarrhea. Am J Transplant, 2005, 5 ( 6 ) : 1383 - 1391.
  • 9尹广,季曙明,殷立平,陈劲松,沙国柱,朱学军,陈惠萍,刘志红,黎磊石.他克莫司在移植肾功能延迟恢复患者中的临床应用[J].肾脏病与透析肾移植杂志,2004,13(2):129-131. 被引量:3
  • 10Hochleitner BW, Bosmiiller C, Nehoda H, et al. Increased tacrolimus levels during diarrhea. Transpl Int, 2001,14 (4) : 230 - 233.

二级参考文献41

  • 1范昱,谢桐.肾移植后慢性排斥的治疗[J].中华器官移植杂志,1993,14(1):35-37. 被引量:9
  • 2张鑫,刘志红,郑敬民,陈朝红,唐政,陈劲松,黎磊石.肾移植患者他克莫司血药浓度的影响因素[J].肾脏病与透析肾移植杂志,2005,14(4):333-338. 被引量:21
  • 3孙启全,黎磊石,唐政,陈劲松,季曙明,沙国柱,程震,曾彩虹,陈惠萍,周虹,刘志红.他克莫司联合霉酚酸酯治疗肾移植术后早期难治性急性体液性排斥的疗效[J].肾脏病与透析肾移植杂志,2006,15(1):12-17. 被引量:9
  • 4Budde K,Smettan S,Fritsche L,et al.Five year outcome of FK506 rescue theraty in late rejection after renal transplantation.Transplant Proc,2002,34:1594
  • 5Jordan ML,Naraghi R,Shapiro R,et al.Tacrolimus for rescue of refractery renal allograft rejection.Transplant Proc,1998,30:1258
  • 6Racusen LC,Solez K,Colvin RB.The Banff 97 working classification of renal allograft pathology.Kidney int,1999,55:713
  • 7Goto T,Kino T,Halanaka H,et al.Discovery of FK506,a noval immunosupprasant isolated from streptomyces tsukubaensis.Transplant Proc,1987,19(1):4
  • 8Starzl TE.First international workshop on FK506:a potential breakthrough in immunosuppression.Transpl Proc,1987,19(1):101
  • 9Sewing K-Fr.Pharmacokinetics,dosing principles and blood level monitoring of FK506.Transplant Proc,1994,26:3267
  • 10Undre NA,Stevenson P,Schafer A.Pharmacokinetics of tacrolimus:clinically relevant aspects.Transplant Proc,1999,31(7A):21s

共引文献22

同被引文献145

引证文献13

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部